Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.

Hideki GotoToshio KitawakiNobuharu FujiiKoji KatoYasushi OnishiNoriko FukuharaTakuji YamauchiKazunori TorataniHiroki KobayashiShota YoshidaMasatoshi ShimoKoichi OnoderaHajime SenjoMasahiro OnozawaKenji HirataIsao YokotaTakanori Teshima

Published in: International journal of clinical oncology (2023)

We report the first real-world data on tisagenlecleucel for r/r B-cell lymphoma in Japan. Tisagenlecleucel is feasible and effective, even in late line treatment. In addition, our results support a new algorithm for predicting the outcomes of tisagenlecleucel.

Keyphrases

diffuse large b cell lymphoma
machine learning
acute myeloid leukemia
acute lymphoblastic leukemia
big data
multiple myeloma
deep learning
adipose tissue
hodgkin lymphoma
data analysis
metabolic syndrome
skeletal muscle
insulin resistance
smoking cessation